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Mood instability and irritability 
as core symptoms of Major 
Depression: an exploration Using 
rasch analysis
Lloyd Balbuena1*, Rudy Bowen1*, Marilyn Baetz1 and Steven Marwaha2
1 Psychiatry, University of Saskatchewan, Saskatoon, SK, Canada, 2 Mental Health and Wellbeing, Warwick Medical School, 
Coventry, UK
Background: Mood instability (MI) and irritability are related to depression but are 
not considered core symptoms. Instruments typically code clusters of symptoms that 
are used to define syndromic depression, but the place of MI and irritability has been 
under-investigated. Whether they are core symptoms can be examined using Rasch 
analysis.
Method: We used the UK Psychiatric Morbidity Survey 2000 data (n = 8,338) to deter-
mine whether the nine ICD/DSM symptoms, plus MI and irritability, constitute a valid 
depression scale. Rasch analysis was used, a method concerned with ensuring that 
items constitute a robust scale and tests whether the count of symptoms reflects an 
underlying interval-level measure. Two random samples of 500 were drawn, serving as 
calibration and validation samples. As part of the analysis, we examined whether the 
candidate symptoms were unidimensional, followed a Guttman pattern, were locally 
independent, invariant with respect to age and sex, and reliably distinguished different 
levels of depression severity.
results: A subset of five symptoms (sad, no interest, sleep, cognition, suicidal ideas) 
together with mood instability and irritability satisfactorily fits the Rasch model. However, 
these seven symptoms do not separate clinically depressed persons from the rest 
of the population with adequate reliability (Cronbach α  =  0.58; Person Separation 
Index = 0.35), but could serve as a basis for scale development. Likewise, the original 
nine DSM depression symptoms failed to achieve satisfactory reliability (Cronbach 
α = 0.67; Person Separation Index = 0.51).
limitations: The time frame over which symptoms were experienced varied, and some 
required recall over the last year. Symptoms other than those examined here might also 
be core depression symptoms.
conclusion: Mood instability and irritability are candidate core symptoms of the depres-
sive syndrome and should be part of its clinical assessment.
Keywords: mood instability, depression, psychometrics, diagnosis, health surveys
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inTrODUcTiOn
Depression is a common condition with an estimated lifetime 
prevalence in the USA of about 16% (1). It is an important cause of 
workdays lost to disability (2) and is as impairing as arthritis, dia-
betes, and cardiovascular disease (3). The cost of sub-syndromal 
symptoms probably exceeds that of formally diagnosed major 
depression (3–6). It is a concern that the incidence of suicide – the 
most tragic consequence of depression – has not decreased over 
decades (7). Clearly, we need to better understand the depressive 
syndrome and the symptoms used in its assessment.
The conceptualization, assessment, and measurement of major 
depression are tricky, and this shows in the poor reliability and 
validity of its instruments (8–10). Non-cohesive symptoms might 
partly explain why specific genetic, biological, or psychological 
underpinnings are poorly understood (11–13). While depressive 
symptoms diverge in their association with external variables – as 
with cognitive and neuro-vegetative symptoms (14) – a particular 
symptom can be shared by different disorders. For example, it is 
unclear whether agitation is an indicator of anxiety or depres-
sion and whether it is because agitation is related to the higher 
construct of distress (14, 15). Two individuals can share the same 
major depression diagnosis without sharing a single symptom 
(16). Calculating the prevalence and burden of depression is 
made challenging by the heterogeneity of studies, partly a result 
of differences in measurement (17).
In clinics worldwide, diagnosing major depression is fairly 
straightforward. Primary care and specialist physicians follow 
the DSM (which requires 5 of 9 symptoms) or the ICD (which 
requires 4 of 10 symptoms) (18). Interestingly, prevalence esti-
mates are similar between systems, although somewhat different 
populations are identified (19). Having equivalent diagnostic 
systems has simplified the work of health systems with regard to 
billing for services and clinical communication (18), but has left 
important conceptual work unattended. Two problems with the 
DSM criteria, and by extension, the ICD were raised by Kendler 
(20). First, the criteria are narrower than the symptoms known to 
the Western tradition of psychiatry, resulting in an impoverished 
concept (20). This is perhaps understandable because a list of 
diagnostic symptoms needs to be brief. Second, the DSM criteria 
are reified, in the sense that they are thought to constitute depres-
sion itself, instead of selected signs of depression (20). In health 
systems where time is a premium, relying solely on the checklist 
of symptoms, and ultimately on symptom counts, is a common 
practice.
Two potential candidate symptoms of the depressive syn-
drome are MI and irritability. By mood, we mean a valenced 
emotional state (i.e., positive or negative) (21) in a patient. 
MI can be defined as “rapid oscillations of intense affect, with 
a difficulty in regulating these oscillations or their behavioral 
consequences” (22). MI is closely associated with depression 
in both cross-sectional and longitudinal studies (23, 24). The 
prevalence of MI is about 14% in the UK general population and 
about 61% in participants with depression (25), suggesting that 
MI could be important in diagnosing depression. MI is central 
to neuroticism (26) that, in turn, is the personality trait most 
consistent predictor of depression (27).
DSM-V and ICD-10 accounts of major depression mention 
irritability in their narrative descriptions, but do not include 
it in the list of diagnostic symptoms (4, 28). Hence, it could be 
ignored by clinicians who follow the nine standard symptoms, 
as if it were an exhaustive list. Yet, it is reported that irritability 
occurs in one-third to one-half of child and adult patients with 
major depression (29–31), and is part of a strong principal factor 
of major depression (29). Irritable depression is also associated 
with greater severity, lower quality of life, and a history of suicidal 
attempts, which is itself a criterion for depression (29). These 
findings, as well as Kendler’s critique suggest that the ICD or DSM 
symptom lists are incomplete.
Our research questions are:
 (i) Do the DSM/ICD symptoms for major depression constitute 
a valid measure?
 (ii) Are MI and irritability symptoms of depression?
We addressed these questions using Rasch analysis, which 
tests a crucial assumption in scales: the total score (or count of 
symptoms) is an adequate, equidistant representation of depres-
sion levels. In brief, the objective of Rasch modeling is to verify 
that questionnaires have the properties of physical measures (e.g., 
a ruler). The units are equally spaced, measure a single attribute 
(i.e., length), and are additive. Moreover, the reading does not 
depend on the properties of the entity being measured or the 
person making the measurement.
MaTerials anD MeThODs
Data
We used data from the 2000 Psychiatric Morbidity Survey (PMS) 
of Great Britain. The main purpose of the survey was to estimate 
the prevalence of psychiatric disorders and their correlates using 
a stratified random multistage design. Participants were 8,580 
adults, aged 16–74  years, living in private households in Great 
Britain. Of these, the 8,338 people (97%) who had complete 
records of symptoms of interest were the population from which 
our calibration and verification samples were drawn. Full details 
of the PMS methods are available in the main survey report (32).
Measures
Depressive Symptoms
Participants were assessed for depression and anxiety disorders 
by trained lay interviewers who used the Clinical Interview 
Schedule-Revised (CIS-R). This is a reliable and valid instrument 
that can be used to algorithmically assign an ICD-10 diagnosis 
(33). We selected CIS-R questions that were similar in mean-
ing and wording to the nine symptoms of major depression 
specified by DSM-V. The DSM-V depression symptoms only 
has “subtle changes” over DSM-IV (34), while both ICD-10 and 
the upcoming ICD-11 are designed to harmonize with DSM 
(35, 36). Where the DSM-V symptoms had multiple parts, we 
combined the participant’s answers to multiple CIS-R questions. 
The CIS-R questions we included for analysis are the following: 
“sad, miserable, or depressed,” “unable to enjoy or take an interest 
FigUre 1 | schematic diagram of analysis steps.
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in things,” “loss of appetite/weight except on a diet,” “problems 
getting to sleep/sleeping more than usual,” “restless, walking 
more slowly, less talkative,” “tired except from doing exercise/
lacking in energy,” “felt guilty/blamed self/felt not as good as 
other people,” “problems concentrating/forgetting things,” “life 
not worth living/wished for death/thought of suicide.” The time 
frame over which symptoms were experienced differed for dif-
ferent symptoms (weeks to years), so the duration and timing of 
occurrence were disregarded.
MI and Irritability
These were assessed within the participant-completed Structured 
Clinical Interview for DSM-IV Axis II Personality Disorders 
(SCID-II): borderline personality disorder section (37). The 
question that assessed MI was “Do you have a lot of sudden mood 
changes?” There were two questions on irritability: (a) “Many 
people become irritable or short tempered at times, though they 
may not show it. Have you felt irritable or short tempered with 
those around you in the past month?” and (b) “During the past 
month did you get short tempered or angry over things which 
now seem trivial when you look back on them?”
analytical strategy
Although Rasch analysis is increasingly used in other medical 
specialties, it is still largely underutilized in psychiatry (38, 39). 
As mentioned in the Section “Introduction,” Rasch analysis 
determines whether mental or psychological scales have the 
characteristics of physical measures. For this to be the case, 
five conditions must be met (Figure 1). First, the instrument is 
designed to measure a single attribute (unidimensionality). Just 
as a ruler measures length only, depression scales must measure 
depression alone. Second, the responses follow a Guttman pattern: 
persons are ranked from lowest to highest levels of the trait, while 
items are ranked by highest to lowest levels of endorsement. The 
appearance of a Guttman pattern is like a staircase. The ranking of 
persons and items in this manner produces units that are interval-
level measures called logits (“log odds unit”). Third, endorsing a 
particular question should be independent of the endorsement 
of another question except with respect to the attribute being 
measured (local independence). This requirement guards against 
spurious correlations – those that are due to external factors, such 
as wording or position in the scale. Fourth, the items and the 
overall instrument must not have differential item or test func-
tion. This means that at the question and instrument levels, there 
must be invariance with respect to person characteristics like age 
and gender. Fifth, the overall scale must be internally consistent 
(as measured by Cronbach’s alpha) and able to distinguish differ-
ent strata of respondents along the latent trait (40, 41).
We performed Rasch analysis in two samples of 500 subjects, 
one serving as calibration and the other as validation sample. 
The requirements, tests performed, and the criteria in each test 
are summarized in Table  1. For the complete description of 
analysis steps, please refer to the Appendix in Data Sheet S1 in 
Supplementary Material.
resUlTs
We refer the interested reader elsewhere (32) for a description 
of the demographic characteristics of all 8,580 PMS participants. 
Our calibration and verification samples were similar in age 
distribution (mean =  45  years), mean frequency of depression 
symptoms endorsed (about four symptoms), sex, and living 
arrangements. Please refer to Table 2 for details.
Unidimensionality
Parallel analysis of the 11 candidate items in the calibration 
sample showed two dimensions (adjusted eigenvalues: 2.82 and 
1.02). In the validation sample, a similar result was reached with 
TaBle 2 | Demographic variables of the calibration and validation 
samples taken from the UK Psychiatric Morbidity survey 2000.
sample 1  
(n = 500)
sample 2  
(n = 500)
p
Mean number of symptoms 
endorsed (of 11 symptoms)
3.83 (2.52) 3.93 (2.46) 0.52
Mean age (SD) 44.48 (15.78) 45.23 (15.64) 0.46
Sex
Male (%) 213 (42.60) 193 (38.60) 0.20
Female (%) 287 (57.40) 297 (61.40)
Living arrangements
Married/cohabiting (%) 273 (54.60) 286 (57.20) 0.70
Single (%) 115 (23.00) 107 (21.40)
Widowed/divorced/separated (%) 112 (22.40) 107 (21.40)
TaBle 1 | assessment of fit with rasch model assumptions and the criteria used.
requirement Test(s) criterion
1. Unidimensional Parallel analysis comparing actual data with artificial data  
(scope: the entire set of questions) (42)
Retain the nth component for which the eigenvalue in the actual data is 
greater than the 95th percentile in 5,000 simulated data (43)
2. Guttman pattern Infit mean square value (scope: per question) Must be between 0.91 and 1.09 (44)
3. Local independence Residual correlations (scope: by pairs of questions) Not greater than 0.2 and p values (with Holm’s adjustment) not greater 
than 0.05 (45, 46)
4. Invariance  (a) Uniform DIF: Mantel-Haenszel test (scope: per question)
 (b) Non-uniform DIF: Breslow-Day (scope: per question)
 (c) Differential Test Functioning: tau-squared: the variance of DIF 
across all items (scope: the entire set of questions)
(a)-(b) Neither of the two tests has a significant value (47)
 (c) tau-squared < 0.07: small DTF  
0.07 < tau-squared < 0.14: medium DTF  
tau-squared > 0.14: large DTF (48)
5. Reliability  (a) Cronbach alpha
 (b) Person Separation Index (scope: the entire set of questions)
 (a) alpha > 0.8
 (b) PSI > 0.7 (41)
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eigenvalues: 2.84 and 1.04. To determine whether MI and/or 
irritability were responsible for violating unidimensionality, we 
omitted them both and performed parallel analysis using only the 
typical nine depression symptoms. Once again, two dimensions 
were detected. The eigenvalues were 2.60 and 1.02 for the calibra-
tion sample and 2.57 and 1.04 for the validation sample. After 
misfitting items (i.e., weight/appetite change, agitation/retarda-
tion, fatigue, self-blame) were dropped, we tested dimensionality 
with the retained items (i.e., sad, lack of interest, sleep problems, 
cognition problems, and suicidal ideas) plus MI and irritability. 
Only one adjusted eigenvalue was greater than one in both the 
calibration and validation samples (1.87 and 1.81, respectively). 
We took these results as evidence that MI and irritability are part 
of the core indicators of depression.
assessment of Fit with a Probabilistic 
guttman Pattern
Of the 11 symptoms we examined, the most common symptom 
was irritability, while MI was the least common. Please refer to 
Table 3 for the complete list of item locations in logits. Figure 2 is 
a visual representation of the item locations and the correspond-
ing fraction of the population that they demarcate.
The symptoms that misfit the Rasch model were weight/
appetite change, agitation/retardation, fatigue, and self-blame. 
With consistent findings in both samples, these symptoms were 
eliminated. See Table 4 for the initial and final symptom lists and 
fit statistics.
Test of local independence
In the calibration sample, large residual correlations were observed 
between the item pairs fatigue and cognition, χ2 = 14.36, df = 1, 
p with Holm’s adjustment = 0.004. The validation sample showed 
a similar large residual correlation for these two items, χ2 = 11.26, 
df = 1, p with Holm’s adjustment = 0.02. After fatigue was elimi-
nated from the symptom list, no large residuals remained.
Differential item/Test Function
With the assessment of differential response by gender, no items 
were flagged for DIF in the calibration sample. In the validation 
sample, irritability showed both uniform and non-uniform 
effects. Female respondents more frequently endorsed irritability, 
and the disparity with male respondents also differed by depres-
sion level. The impact of DIF by gender with respect to irritability 
had a medium sized effect on the test for the validation sample. 
See Table 5 for details.
With the DIF assessment by age group, cognition showed 
both uniform DIF. In the calibration sample, respondents above 
45  years of age endorsed cognitive problems more frequently. 
In the validation sample, respondents above age 45 endorsed 
irritability more frequently. Both cognition and irritability had 
large test effects in both samples. See Table 6 for details.
Test reliability
The PSI for the initial 11 symptoms was 0.60 for the calibration 
sample and 0.58 for the validation sample. For the seven retained 
symptoms (i.e., sad, no interest, sleep, cognition, suicidal ideas, 
MI, irritability) the PSIs were 0.38 and 0.35 for the calibration 
and validation samples, respectively. Cronbach alphas for the 11 
symptoms (nine original, plus MI and irritability) were 0.71 and 
0.70 for the calibration and validation samples, respectively, and 
0.58 for both samples for the seven retained symptoms.
In post hoc analysis, we examined the PSI and alpha for the 
standard nine DSM/ICD symptoms. PSIs were 0.52 and 0.51, and 
Cronbach alphas were 0.70 and 0.67 for calibration and valida-
tion, respectively.
FigUre 2 | Distribution of persons and items along the depression latent trait.
TaBle 3 | item difficulties (in logits) in the calibration and validation datasets.
item calibration Validation
item difficulties in  
the initial list
item difficulty after  
eliminating misfitting items
item difficulties  
in the initial list
item difficulty (after eliminating  
misfitting items)
1. Sad 0.05 0.06 −0.04 −0.02
2. No interest 1.60 1.57 1.53 1.50
3. Weight/appetite change 0.72 N/A 0.74 N/A
4. Sleep 0.17 0.18 0.14 0.14
5. Agitation, retardation 2.23 N/A 2.00 N/A
6. Fatigue −0.25 N/A −0.19 N/A
7. Self-blame 2.23 N/A 2.18 N/A
8. Cognition 0.39 0.39 0.40 0.40
9. Suicidal ideas 1.14 1.13 1.05 1.03
10. MI 2.33 2.29 2.10 2.05
11. Irritability −0.77 −0.75 −0.96 −0.92
TaBle 4 | item fit statistics in the calibration and validation datasets.
item calibration Validation
infit t in the initial list infit t after eliminating 
misfitting items
infit t in the initial list infit t after eliminating 
misfitting items
1. Sad 0.91 0.93 0.94 0.93
2. No interest 0.97 1.00 1.00 1.04
3. Weight/appetite change 1.19 N/A 1.14 N/A
4. Sleep 1.08 1.07 1.04 1.02
5. Agitation, retardation 0.80 N/A 0.83 N/A
6. Fatigue 0.97 N/A 0.99 N/A
7. Blame no good 0.81 N/A 0.82 N/A
8. Cognition 0.96 0.98 0.97 0.97
9. Suicidal ideas 1.11 1.04 1.10 1.04
10. MI 1.01 0.96 1.00 0.97
11. Irritability 1.05 1.00 1.09 1.03
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TaBle 5 | DiF by gender.
item sample 1 (n = 500) sample 2 (n = 500)
Mantel–
haenszel χ2♣
p-Value Breslow-Day† p-Value combined 
decision rule*
Mantel– 
haenszel χ2♣
p-Value Breslow-Day† p-Value combined 
decision rule*
Sad 0.85 0.36 5.34 0.25 Ok 1.17 0.28 4.00 0.55 Ok
No interest 0.03 0.85 0.65 0.99 Ok 0.00 0.97 2.39 0.79 Ok
Sleep 1.82 0.18 7.54 0.18 Ok 5.00 0.03 2.70 0.75 Ok
Cognition 2.94 0.09 4.15 0.53 Ok 1.82 0.18 2.47 0.78 Ok
Suicidal ideas 0.5 0.82 12.04 0.03 Ok 0.41 0.52 2.36 0.80 Ok
Mood instability 0.07 0.79 3.36 0.50 Ok 0.19 0.66 4.32 0.50 Ok
Irritability 1.00 0.32 4.60 0.33 Ok 9.87 0.00* 4.10 0.54 Flag
Differential test 
function (DTF)
Tau2: −0.001 (small effect) Tau2: 0.11 (medium effect)
♣Tests uniform DIF which means that one group systematically scores higher.
†Tests non-uniform DIF which means that one group scores higher at lower levels of depression but the pattern reverses at higher levels of depression.
*An item is flagged for differential function if either the Mantel-Haenszel or the Breslow-Day test is significant.
TaBle 6 | DiF by age group.
item sample 1 (n = 500) sample 2 (n = 500)
Mantel–
haenszel χ2♣
p-Value Breslow-Day† p-Value combined 
decision rule*
Mantel–
haenszel χ2♣
p-Value Breslow-Day† p-Value combined 
decision rule*
Sad 1.29 0.26 1.82 0.77 Ok 2.27 0.13 1.65 0.90 Ok
No interest 1.68 0.19 1.98 0.85 Ok 0.24 0.62 2.81 0.73 Ok
Sleep 0.20 0.66 1.68 0.89 Ok 6.36 0.01 2.41 0.79 Ok
Cognition 12.26 <0.001* 3.19 0.67 Flag 3.86 0.05 6.74 0.24 Ok
Suicidal ideas 0.27 0.61 4.63 0.46 Ok 3.82 0.05 5.96 0.31 Ok
Mood instability 6.62 0.01 2.56 0.63 Ok 3.11 0.07 4.23 0.52 Ok
Irritability 8.50 0.004 6.35 0.17 Ok 10.95 <0.001* 2.80 0.73 Flag
Differential test 
function (DTF)
Tau2: 0.29 (large effect) Tau2: 0.21 (large effect)
♣Tests uniform DIF which means that one group systematically scores higher.
†Tests non-uniform DIF which means that one group scores higher at lower levels of depression but the pattern reverses at higher levels of depression.
*An item is flagged for differential function if either the Mantel-Haenszel or the Breslow-Day test is significant.
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DiscUssiOn
In this work, we sought to clarify what symptoms form the most 
statistically cohesive set to measure depression as a construct. 
We now discuss the practical and theoretical implications of our 
findings.
Measuring Depression
We found that the nine depression symptoms in the DSM/ICD 
systems are not unidimensional. In practice, this means that the 
“5 of 9” rule (or “4 of 10” for ICD) is probably not warranted 
because the symptoms do not all tap the same attribute. A more 
homogeneous set of indicators is achieved by removing weight 
and appetite change, agitation and retardation, and feelings of 
worthlessness and inappropriate guilt and fatigue from the core 
of the major depression syndrome. The findings that MI and 
irritability fit the Rasch model indicates that they belong to the 
core network/cluster of symptoms that includes sadness and 
anhedonia (49).
While irritability appears to be endorsed differentially by sex 
and by age group, MI is invariant with respect to both charac-
teristics. That irritability is identified as a DIF item should not 
automatically exclude it from the list. One possibility is to adjust 
for the DIF effect of gender and/or age in assessing the severity of 
depression (50). This would be difficult to implement in a paper 
and pencil test, but could be solved by computer adaptive testing 
that takes covariates into account.
Seven items – sad, lack of interest, sleep, cognition, suicidal 
ideas, MI, and irritability – could serve as the kernel for a depres-
sion measure, but on their own do not reliably separate depressed 
persons from the rest. Likewise, the list of DSM/ICD symptoms 
fails the typical criterion for internal consistency (alpha < 0.80) 
and also falls short of distinguishing the depressed from the rest 
(PSI < 0.70). Clinical judgment and contextual information may 
need to be taken into account apart from the canonical list of 
symptoms. For use outside of the clinic, scales such as the PHQ-9, 
Beck Depression Inventory, HADS, CES-D, and the like are only 
recently being examined using item response theory (51–53).
reconceptualizing Depression
Mood instability is common in depression (23, 25) and has been 
shown to be a precursor of depression (24). Our current results 
provide evidence that MI is a symptom of depression. According 
to DSM, relatively short durations of MI phases would not meet 
7Balbuena et al. Rasch Analysis of Major Depression
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episode criteria for major depression (2 weeks) or for hypomania 
(4 days) (4). If the patient reports rapid mood fluctuations, it is 
typical to either dismiss MI as clinically unimportant or to con-
currently diagnose a personality disorder, particularly borderline 
personality disorder where both MI and irritability are DSM-V 
criteria (4). Unfortunately, people who do not fulfill duration 
criteria may also be considered “well” or at least not depressed 
and receive no treatment (54), but these people are at higher risk 
of developing future depression (55). The evidence indicates that 
intense and frequent mood swings are associated with severe 
distress (56, 57), and there is merely a quantitative difference 
between the mood fluctuations of normal individuals and those 
of patients (58). MI is linked to other indicators of distress and 
impairment such as health care utilization, medication use, and 
suicidal thoughts (25, 59) and has recently been proposed to fit 
the characteristics of the Research Domain Criteria (60).
Irritability is associated with emotional lability in patients 
with unipolar depression (30) and in university students (30, 
61) and is common in depression (29, 30). Mixed depression, 
which may be defined as “an overlapping of manic and depressive 
symptoms” includes irritability and emotional lability among its 
symptoms (62). This presentation is characterized by psychic and 
motor agitation, accompanied by intense suffering, which put 
the patient at increased risk of suicide (54). Irritability could be 
a core symptom of depression (29), an indicator of a more severe 
and chronic course (30, 63) or a feature of bipolar disorders (64). 
DSM-V has included irritability as a core symptom of mania, gen-
eralized anxiety disorder, and borderline personality disorder. but 
excluded it as a symptom of major depression. It has previously 
been rejected as a symptom of major depression as it does not 
appreciably increase the prevalence above that of sadness and loss 
of interest (29, 65). Increased prevalence is not necessarily a good 
basis for defining a syndrome. Conversely, irritability, along with 
MI, could lead to longstanding interpersonal and adjustment 
difficulties that could lead to depression (30, 49). In summary, 
both MI and irritability are observed in a range of psychiatric 
disorders.
It is uncertain whether agitation and retardation are specific 
distinguishing features of major depression, melancholia, mixed 
mood states, atypical depression, bipolar II depression, or anxiety 
comorbid with mood disorders (66, 67). Agitation is a defining 
characteristic of a proposed mixed depressive state that has both 
melancholic and excitatory features, but which does not have the 
levity in mood of hypomanic patients (62). Our finding is more 
consistent with a major depression study that reported that agita-
tion could be dropped from the definition of major depression 
with no loss of validity (68).
The Feighner symptom of “self-reproach or guilt” was 
expanded in DSM-III to include “feelings of worthlessness …” as 
part of the DSM trend to broaden the criteria for major depres-
sion (69). There is a clear semantic difference between guilt 
(worry) about past misdeeds and anxiety (worry) about future 
threats and perhaps feeling helpless, but this distinction might 
not be meaningful for people with common mental disorders, 
high comorbidity, or high distress (70–73). Our results replicate 
findings of a previous Rasch analysis of the PHQ-9 scale that guilt 
was not coherent with the model of depression (51).
We eliminated fatigue because of higher than expected corre-
lation with cognitive problems. This could be the result of similar 
wording: both symptoms are presented as diminished ability. An 
alternative to eliminating this item is rewording either fatigue or 
cognitive problems. Retaining this item is probably the more pru-
dent course of action. Although one study reported that fatigue 
is not unidimensional with the other depression symptoms (74), 
several other studies reported that it satisfies the Rasch model 
(11, 52, 75).
It should be emphasized that the misfitting items are fre-
quently experienced by patients with major depression. What 
is in question is whether they are central to the network of 
symptoms comprising the depressive syndrome and whether 
they are useful in its assessment. The search for underlying 
biological or psychological aberrations (76) or treatment (77) 
for depression is probably hampered by a heterogeneous cluster 
of symptoms.
Our study has several limitations. First, the data are based on 
retrospective recall with all of the disadvantages of this method 
(78). People who are depressed have a general negative recall bias 
that might affect reporting of symptoms (78). Second, the CIS-R 
was designed to elicit the ICD-10 criteria for depression, although 
the symptoms are very similar to those of DSM-V. Third, we did 
not consider duration criteria for the individual symptoms, and 
thus cannot be certain that all symptoms occurred at the same 
time. However, all duration criteria of major depression and 
similar groupings are arbitrary and, theoretically, symptoms may 
occur sequentially and still indicate the same syndrome (55, 79). 
Fourth, we studied MI and irritability, but other common symp-
toms such as anxiety, rumination and physical symptoms should 
be studied (73, 80). Fifth, we performed DIF analysis only by age 
and gender in a British sample, so further analysis is required to 
determine if MI and irritability are part of the syndrome across 
cultures. The differential item status of sleep, irritability, and MI 
should be addressed by future work. Sixth, while MI and irritabil-
ity were shown to load on a single factor with depression, we did 
not have an independent external criterion to serve as a reference. 
Finally, the PMS did not assess bipolar disorder so it is possible 
that some of the respondents had bipolar, instead of unipolar 
depression. We do not think this limitation undermines our 
findings because MI is a feature of a wide range of psychiatric dis-
orders (22, 81) and, second, the prevalence of people with bipolar 
depression in the sample in comparison to unipolar depression 
is likely to have been small. It would be beneficial in replication 
studies to correlate the scores of patients in our proposed 7-item 
scale to standard psychometric questionnaires, such as the Mood 
Disorders Questionnaire or the Affective Lability Scale.
A strength of our study is that it was based on empirical data 
obtained from an epidemiological sample of the population. 
Accordingly, it was not constrained by a pre-selected sample with 
major depression as diagnosed by the criteria being studied.
cOnclUsiOn
Mood instability and irritability are candidate core symptoms 
of the depressive syndrome and should be part of its clinical 
assessment.
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